Compounds > 6-fluoro-3-tyrosine
Page last updated: 2024-09-03

6-fluoro-3-tyrosine and Atherosclerotic Parkinsonism

6-fluoro-3-tyrosine has been researched along with Atherosclerotic Parkinsonism in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bahri, MA; Becker, G; Garraux, G; Hustadt, F; Lemaire, C; Luxen, A; Michel, A; Plenevaux, A1
Bankiewicz, KS; Eberling, JL; Emborg, ME; Nagy, D; Oiwa, Y; Pivirotto, P1
Bankiewicz, KS; Eberling, JL; Jagust, WJ; Jordan, S; VanBrocklin, HF1
Bankiewicz, KS; Bringas, J; Eberling, JL; Jagust, WJ; Pivirotto, P; Taylor, S; VanBrocklin, HF1
Bankiewicz, KS; Bringas, J; Budinger, TF; Cunningham, J; Eberling, JL; Harvey-White, J; Jagust, W; Kohutnicka, M; Pivirotto, P1

Other Studies

5 other study(ies) available for 6-fluoro-3-tyrosine and Atherosclerotic Parkinsonism

ArticleYear
Comparative assessment of 6-[
    Journal of neurochemistry, 2017, Volume: 141, Issue:4

    Topics: Animals; Apomorphine; Aromatic-L-Amino-Acid Decarboxylases; Dihydroxyphenylalanine; Disease Models, Animal; Dopamine; Fluorine Radioisotopes; Image Processing, Computer-Assisted; Male; Neostriatum; Oxidopamine; Parkinson Disease; Parkinson Disease, Secondary; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Receptors, Presynaptic; Stereotyped Behavior; Tyrosine

2017
Overlesioned hemiparkinsonian non human primate model: correlation between clinical, neurochemical and histochemical changes.
    Frontiers in bioscience : a journal and virtual library, 2003, Sep-01, Volume: 8

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Brain Chemistry; Carotid Arteries; Corpus Striatum; Disease Models, Animal; Dopamine; Female; Fluorine Radioisotopes; Histocytochemistry; Humans; Injections, Intra-Arterial; Macaca mulatta; Male; Neurochemistry; Parkinson Disease, Secondary; Parkinsonian Disorders; Tomography, Emission-Computed; Tyrosine; Tyrosine 3-Monooxygenase

2003
PET studies of functional compensation in a primate model of Parkinson's disease.
    Neuroreport, 1997, Aug-18, Volume: 8, Issue:12

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Corpus Striatum; Disease Progression; Dopamine Agents; Fluorine Radioisotopes; Macaca mulatta; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Neurotoxins; Pargyline; Parkinson Disease, Secondary; Tomography, Emission-Computed; Tyrosine

1997
A novel MPTP primate model of Parkinson's disease: neurochemical and clinical changes.
    Brain research, 1998, Sep-14, Volume: 805, Issue:1-2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Agents; Macaca mulatta; Parkinson Disease, Secondary; Tomography, Emission-Computed; Tyrosine

1998
Convection-enhanced delivery of AAV vector in parkinsonian monkeys; in vivo detection of gene expression and restoration of dopaminergic function using pro-drug approach.
    Experimental neurology, 2000, Volume: 164, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Aromatic-L-Amino-Acid Decarboxylases; Carbidopa; Catheterization; Caudate Nucleus; Cell Line; Dependovirus; Dopamine; Drug Administration Routes; Drug Combinations; Fluorine Radioisotopes; Genetic Therapy; Genetic Vectors; Levodopa; Macaca mulatta; Magnetic Resonance Imaging; Neurons; Parkinson Disease, Secondary; Prodrugs; Putamen; Tomography, Emission-Computed; Tyrosine; Tyrosine 3-Monooxygenase

2000